Insulin glargine and lixisenatide Subcutaneous and Phenobarbital Injection
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Phenobarbital Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: phenobarbital
Brand name: Solfoton, Luminal
Synonyms: Phenobarbital, PHENobarbital
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Phenobarbital Oral Solution
- Insulin glargine and lixisenatide Subcutaneous-Phenobarbital Sodium
- Insulin glargine and lixisenatide Subcutaneous-Phenobarbital Sodium Injection
- Insulin glargine and lixisenatide Subcutaneous-Phenobarbital Tablets
- Insulin glargine and lixisenatide Subcutaneous-Phenobarbital with Belladonna Alkaloids Elixir
- Insulin glargine and lixisenatide Subcutaneous-Phenohytro
- Phenobarbital Injection-Insulin glargine, recombinant Subcutaneous
- Phenobarbital Injection-Insulin glulisine
- Phenobarbital Injection-Insulin Glulisine (Cartridges and Pens)
- Phenobarbital Injection-Insulin Glulisine (Vials)
- Phenobarbital Injection-Insulin glulisine Subcutaneous
- Phenobarbital Injection-Insulin human inhaled Inhalation